Jefferies Group’s Redhill Biopharma RDHL Stock Holding History

Jefferies Group’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40	Closed	-$275K	–	1965
2021 Q2	$275K	Buy	+40	New	+$276K	﹤0.01%	1323

Other funds holding RDHL

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group's RDHL Position: Q3 2021 in Review

Jefferies Group sold out of Redhill Biopharma (RDHL) in Q3 2021, closing a stake of 40 shares — an estimated $275K sold.

Jefferies Group first reported a position in RDHL in Q2 2021 and held it in 1 quarter. The position peaked at $275K in Q2 2021. 53 funds tracked by Wall St. Rank hold RDHL as of Q3 2021.

Jefferies Group reported no remaining Redhill Biopharma position as of Q3 2021 after selling out during the quarter.
Jefferies Group sold 40 Redhill Biopharma shares in Q3 2021, an estimated $275K.
Jefferies Group first reported a position in Redhill Biopharma in Q2 2021 and held it in 1 quarter.
Jefferies Group's Redhill Biopharma position peaked at $275K in Q2 2021.
53 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.